<DOC>
	<DOCNO>NCT02176642</DOCNO>
	<brief_summary>This randomized double-blind placebo-controlled clinical trial posterior tibial nerve stimulation ( PTNS ) plus extended release oxybutynin versus PTNS alone ( placebo pill ) woman undergo treatment urgency urinary incontinence ( UUI ) . The investigator hypothesize combination therapy PTNS anticholinergic medication result significant incremental improvement UUI symptom achieve PTNS alone . In addition , investigator hypothesize addition anticholinergic PTNS result great improvement patient ' perception treatment response , symptom distress , quality life PTNS alone . Specific Aim 1 : To compare change , baseline , mean number UUI episode per day use 3-day bladder diary PTNS plus anticholinergic medication versus PTNS plus placebo woman undergo treatment UUI . Specific Aim 2 : To compare change , baseline , 24hr pad weight PTNS plus anticholinergic medication versus PTNS plus placebo . Specific Aim 3 : To compare subjective treatment response , symptom distress , quality life PTNS plus anticholinergic medication versus PTNS plus placebo utilizing Patient Global Impression Improvement ( PGI-I ) Overactive Bladder Questionnaire Short Form ( OABq-SF ) . An interim analysis conduct independent entity 50 participant complete study protocol . A Data Safety Monitoring Board utilize study utilizes FDA approve treatment urgency urinary incontinence .</brief_summary>
	<brief_title>Comparison Combination Therapy v Single Agent Therapy Treatment Urge Incontinence .</brief_title>
	<detailed_description />
	<mesh_term>Urinary Incontinence , Urge</mesh_term>
	<mesh_term>Oxybutynin</mesh_term>
	<mesh_term>Mandelic Acids</mesh_term>
	<criteria>Female patient &gt; 18 year age &gt; 3 UUI episode 3day bladder diary Urge predominant ( &gt; 50 % total incontinence episode ) urinary incontinence base threeday bladder diary Existing insurance coverage PTNS therapy . Ability undergo weekly PTNS treatment clinic 6 week period time complete study relate item Not anticholinergic beta agonist medication , , willing undergone three week washout period prior randomization Any previous PTNS therapy , intradetrusor botulinum toxin injection , implanted sacral neuromodulation Contraindication anticholinergic therapy ( narrowangle glaucoma gastric retention ) PTNS therapy ( implanted pacemaker/defibrillator peripheral neuropathy ) Symptomatic urinary tract infection resolve prior randomization Surgical treatment stress urinary incontinence pelvic organ prolapse recommend planned time enrollment Surgically alter detrusor muscle Known diagnosis history neurogenic bladder , post void residual volume &gt; 150ml , bladder malignancy , interstitial cystitis/painful bladder syndrome , pelvic radiation Surgery pelvic organ prolapse stress urinary incontinence within previous 3 month Pregnancy , lactation , plan pregnancy study period</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Urinary Urge Incontinence</keyword>
	<keyword>Posterior Tibial Nerve Stimulation</keyword>
	<keyword>PTNS</keyword>
	<keyword>Neuromodulation</keyword>
	<keyword>Oxybutynin</keyword>
	<keyword>Anticholinergic Medication</keyword>
</DOC>